deltatrials
Recruiting INTERVENTIONAL NCT06616649

Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.

Sponsor: M.D. Anderson Cancer Center

Conditions Peripheral Neuropathy Due to Chemotherapy
Interventions Spinal cord stimulator implant
Updated 3 times since 2024 Last updated: Apr 28, 2026 Started: Jul 14, 2025 Primary completion: Jul 1, 2027 Completion: Jul 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06616649, this observational or N/A phase trial focuses on Peripheral Neuropathy Due to Chemotherapy and remains actively recruiting participants. Sponsored by M.D. Anderson Cancer Center, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Study Description(click to expand)

Primary Objective: To explore the impact of using closed loop spinal cord stimulation (SCS) on pain control, quality of life, and pain medication use in patients suffering from chemotherapy induced peripheral neuropathy (CIPN). Secondary Objective: To assess the relationship between pain control from closed loop spinal cord stimulation and any associated changes in quantitative sensory testing (QST) and quantitative gait testing (QGT).

Primary Objective:

To explore the impact of using closed loop spinal cord stimulation (SCS) on pain control, quality of life, and pain medication use in patients suffering from chemotherapy induced peripheral neuropathy (CIPN).

Secondary Objective:

To assess the relationship between pain control from closed loop spinal cord stimulation and any associated changes in quantitative sensory testing (QST) and quantitative gait testing (QGT).

Status Flow

~Oct 2024 – ~Nov 2025 · 13 months · monthly snapshotNot Yet Recruiting~Nov 2025 – ~May 2026 · 6 months · monthly snapshotRecruitingMay 4, 2026 – present · 3 months · daily APIRecruiting

Change History

3 versions recorded

  1. May 4, 2026 — Present [daily]

    Recruiting

    Phase: NA → None

  2. Nov 2025 — May 2026 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Oct 2024 — Nov 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

To explore the benefits of using closed loop spinal cord stimulation (SCS) in the treatment of patients experiencing painful chemotherapy induced peripheral neuropathy (CIPN) by assessing changes in pain, quality of life, pain medication use, sensory improvement through quantitative sensory testing, and improvement of gait through quantitative gait testing.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • Saluda Medical Pty Ltd
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations